RPC (RES) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
3 Apr, 2026Executive summary
Annual Meeting scheduled for April 28, 2026, with record date of March 2, 2026.
Proxy materials include proposals to elect directors, ratify auditor, vote on executive compensation, and approve amendments to the 2024 Stock Incentive Plan.
Supplement adds three proposals: ratification of performance stock units for CEO and Executive Chairman, and amendments to the Stock Incentive Plan.
Voting matters and shareholder proposals
Election of ten directors for one-year terms expiring in 2027.
Ratification of Grant Thornton LLP as independent auditor for fiscal year 2026.
Nonbinding advisory vote on executive compensation (say-on-pay).
Proposal 5: Ratification of performance stock units granted to CEO in 2025 and 2026, exceeding annual plan limits.
Proposal 6: Ratification of performance stock units granted to Executive Chairman in 2026, exceeding annual plan limits.
Proposal 7: Amendments to the 2024 Stock Incentive Plan to remove individual annual grant limits for all except non-employee directors, and set a $750,000 annual cap for non-employee directors.
Board of directors and corporate governance
Board formed a special committee of three independent directors to review and respond to a stockholder demand regarding plan violations.
Board recommends approval of all proposals and has ratified the disputed awards subject to shareholder approval.
Latest events from RPC
- Annual meeting to vote on board nominees, auditor ratification, and executive compensation.RES
Proxy Filing18 Mar 2026 - Director elections, auditor ratification, and executive pay are up for vote at the 2026 meeting.RES
Proxy Filing18 Mar 2026 - Q3 2025 revenue rose 6% sequentially and 32% year-over-year to $447.1M, but Q4 faces headwinds.RES
Q3 20256 Feb 2026 - 2025 revenue up 15%, but Q4 loss and margin pressure from wireline cable expense and industry headwinds.RES
Q4 20256 Feb 2026 - Net income rose 18% sequentially to $32.4M on improved margins despite lower revenue.RES
Q2 20242 Feb 2026 - Q3 2024 revenue fell 7% sequentially to $337.7M, but cash and liquidity remain strong.RES
Q3 202418 Jan 2026 - Q4 2024 revenue dipped 1% as margins compressed, but strong cash flow and liquidity were maintained.RES
Q4 20249 Jan 2026 - Q1 revenue and earnings declined, but EBITDA margin improved and Pintail acquisition closed.RES
Q1 202524 Dec 2025 - Up to $300M in securities and 127M shares registered for sale; proceeds support growth and flexibility.RES
Registration Filing16 Dec 2025